| abstract |
A nutraceutical designed for support of immune compromised patients which when administered to patients with immune compromised systems caused by diseases such as HIV, cancer, chemotherapy or radiotherapy will be utilised as a precursor in nucleotide synthesis. The essential amino acid in this nutraceutical will supplement the body's own production of glutamine which is required by the body during rapid cell division and during the production of antibodies. The nutraceutical also provides an adequate level of anti-oxidant vitamins which play a preventative role in the development of cancer by removing free radicals. The composition essentially comprises glutamine or a glutamine-rich peptide, beta-carotene, vitamins B1, B2, B6, B12, C and E and a source of selenium such as sodium selenite. |